ライフサイエンスコーパス: bedtime

1 mg (P <0.01 vs. omeprazole twice daily plus bedtime).

2 east a few nights per week within 1 h before bedtime.

3 h reading a printed book in the hours before bedtime.

4 zepam or high-dose melatonin taken orally at bedtime.

5 no treatment administered 30 minutes before bedtime.

6 te-release niacin (</= 150 mg) as placebo at bedtime.

7 tivity, and delirium during the hours before bedtime.

8 mg [n=106]) or placebo (n=103) 30 min before bedtime.

9 larly that administered in the evening or at bedtime.

10 e light intensity was the same as before the bedtime.

11 with omeprazole twice daily with placebo at bedtime.

12 28 ppm) NaF or the two-solution rinse before bedtime.

13 ing the first non-REM sleep period at normal bedtime.

14 with those who maintained regular nocturnal bedtimes.

15 alternative regimens of melatonin (5.0 mg at bedtime, 0.5 mg at bedtime, and 0.5 mg taken on a shifti

16 00 mg BMS-663068 plus 100 mg ritonavir every bedtime, 1200 mg BMS-663068 plus 100 mg ritonavir Q12H,

17 nitiated therapy with thalidomide, 200 mg at bedtime (18 patients), or 300 mg at bedtime (4 patients)

18 reported sleep duration was 07:07 +/- 01:31 (bedtime 22:32 +/- 01:27, wake up time: 06:17 +/- 01:25 h

19 00 mg at bedtime (18 patients), or 300 mg at bedtime (4 patients).

20 bjects had acid breakthrough with placebo at bedtime; 7 with omeprazole at bedtime (P = NS); 4 with r

21 Bedtime access to and use of a media device were signifi

22 had been administered to their child before bedtime) according to a partially double-blind randomiza

23 CAI administration at bedtime ameliorated gastrointestinal complaints in many

24 The delay region started a few hours before bedtime and extended through the night.

25 grade average associates with later weekend bedtime and smaller grey matter volumes in medial brain

26 finger-tapping motor sequence task (MST) at bedtime and tested the following morning.

27 olume correlates inversely with both weekend bedtime and wake up time, and also with poor school perf

28 Practitioners should encourage regularity in bedtimes and rise times as a first step in treatment, an

29 nsomnia, the authors found that regularizing bedtimes and rise times was often sufficient to bring ab

30 men maintain nearly identical and consistent bedtimes and wake times.

31 s of melatonin (5.0 mg at bedtime, 0.5 mg at bedtime, and 0.5 mg taken on a shifting schedule) for je

32 nts is required to minimize device access at bedtime, and future research is needed to evaluate the i

33 trough of mean IOP occurred just before the bedtime, and then IOP gradually increased and peaked at

34 dtime (P = NS); 4 with ranitidine, 150 mg at bedtime; and 3 with ranitidine, 300 mg at bedtime (P < 0

35 ne, waking (AOR = 2.6, 95% CI: 1.4, 5.1) and bedtime (AOR = 2.3, 95% CI: 1.2, 4.6).

36 95% confidence interval (CI): 1.8, 7.9) and bedtime (AOR = 2.5, 95% CI: 1.3, 4.9); dopamine, waking

37 y activity and of light exposure, with later bedtimes ( approximately 1 h) associated with more eveni

38 ith type 1 DM, physiologic replacement, with bedtime basal insulin and a mealtime rapid-acting insuli

39 ujube leaf infusion as a healthy antioxidant bedtime beverage, and associate it to an unreported anti

40 ba Mill., jujube, leaf infusions are popular bedtime beverages as they improve sleep by soothing the

41 Parentally set bedtimes can be effective in increasing the sleep durati

42 leep restriction to 5 h with fixed nocturnal bedtimes (circadian alignment) or with bedtimes delayed

43 who were receiving clozapine monotherapy at bedtime completed the MATRICS Consensus Cognitive Batter

44 s from meals and snacks consumed during each bedtime condition.

45 by 122 +/- 25 min per night during the 5.5-h bedtime condition.

46 Bedtime cortisol levels did not differ significantly bet

47 urnal bedtimes (circadian alignment) or with bedtimes delayed by 8.5 h on 4 of the 8 days (circadian

48 eep in cirrhosis was associated with delayed bedtime, delayed wake-up time, and evening chronotypolog

49 cid (UDCA) (10-12 mg/kg/d) taken as a single bedtime dose.

50 Mean achieved bedtime doses were 15.6 mg of prazosin (SD=6.0) and 18.8

51 rovided urine samples for 3 days (waking and bedtime) during midpregnancy.

52 ed at wakeup, 30 min after awakening, and at bedtime each day.

53 ventions involved 3 inpatient days with 10-h bedtimes, followed by 8 inpatient days of sleep restrict

54 ents) or placebo (56 patients) once daily at bedtime for 12 weeks in a double-blind study.

55 GHRH (1 mg/d), or placebo 30 minutes before bedtime for 20 weeks.

56 24 h at a fixed clock time 1 h before target bedtime for 26 weeks.

57 ary cortisol samples collected at waking and bedtime for children on 3 separate days.

58 maximum dose of 5 mg midmorning and 20 mg at bedtime for men and 2 mg midmorning and 10 mg at bedtime

59 h acetazolamide or placebo, taken 1 h before bedtime for six nights with 2 wk of washout.

60 or 274 mg of ADS-5102 administered orally at bedtime for up to 25 weeks.

61 ime for men and 2 mg midmorning and 10 mg at bedtime for women.

62 acebo daily, one hour before their preferred bedtime, for three to nine weeks.

63 lutide 1.5 mg, dulaglutide 0.75 mg, or daily bedtime glargine.

64 3819 patients) once daily between dinner and bedtime in a double-blind, treat-to-target, event-driven

65 Montelukast, 10 mg once daily at bedtime; inhaled beclomethasone, 200 microg twice daily,

66 ived inhaled insulin before each meal plus a bedtime injection of ultralente insulin, performed home

67 ial Technosphere inhaled insulin powder plus bedtime insulin glargine; or twice daily premixed biaspa

68 This article discusses using bedtime insulin with oral agents, basal-prandial insulin

69 nal conclusions of meaningful effects of the Bedtime Learning Together (BLT) math app on children's m

70 A single dose (1.76 +/- 0.41 g/kg) of UCS at bedtime maintains plasma glucose concentrations > or = 3

71 ADS-5102, 274 mg at bedtime, may be an effective treatment for LID.

72 a strong and consistent association between bedtime media device use and inadequate sleep quantity (

73 signed to daily treatment with bright light, bedtime melatonin, both or placebos only in a 3.5-year d

74 In patients with type 2 DM, adding bedtime neutral protamine Hagedorn (isophane) insulin to

75 rtile range increase in mean log cortisol at bedtime (odds ratio, 2.2; 95% confidence interval, 1.09-

76 Bedtime ranitidine is more effective than bedtime omeprazole on residual nocturnal acid secretion

77 ional, and physical states were completed at bedtime on each of three consecutive days.

78 bedtime with that of a dose of ranitidine at bedtime on residual nocturnal acid secretion in patients

79 ticipated each in four experiments involving bedtime oral administration of placebo, 2.5, 3.0, and 3.

80 at bedtime; and 3 with ranitidine, 300 mg at bedtime (P < 0.05, ranitidine vs. placebo).

81 ith placebo at bedtime; 7 with omeprazole at bedtime (P = NS); 4 with ranitidine, 150 mg at bedtime;

82 nsion treatment time (on awakening versus at bedtime; per 1-SD elevation: hazard ratio, 1.44; 95% con

83 90 +/- 369 kcal/d during the 5.5-h and 8.5-h bedtime periods, respectively; P = 0.58), and we found n

84 llowed by different treatment supplements at bedtime: placebo; additional omeprazole, 20 mg; ranitidi

85 ith thalidomide 100 to 200 mg orally (PO) at bedtime (qhs) with serial increments of 50 to 100 mg at

86 .023) and negatively correlated with in vivo bedtime (r = -0.54; P = 0.020).

87 Bedtime ranitidine is more effective than bedtime omepra

88 Additional omeprazole at bedtime reduced the percentage of time with intragastric

89 Ranitidine at bedtime reduced this parameter more, 5% with 150 mg and

90 Recurrent bedtime restriction can modify the amount, composition,

91 ity, separation anxiety, nighttime fears and bedtime rituals, cognitive deficits, oppositional behavi

92 Prazosin (mean dose=9.5 mg/day at bedtime, SD=0.5) was superior to placebo for the three p

93 ddlers (n = 80) during the presentation of a bedtime story during natural sleep.

94 received preprandial inhaled insulin plus a bedtime subcutaneous ultralente insulin injection.

95 Twice daily (after breakfast and before bedtime), the subjects received a one-minute rinse with

96 Bedtime use of insulin glargine results in fewer episode

97 the effect of a third dose of omeprazole at bedtime with that of a dose of ranitidine at bedtime on